Clinical trial
Safety and Efficacy of Psilocybin for the Treatment of Headache Disorders: Sub-Study II
NCT03806985 is registered in ClinicalTrials.gov with Yale University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety and Efficacy of Psilocybin for the Treatment of Headache Disorders: Sub-Study II
- Lead sponsor
- Yale University
- Phase
- Phase 1
- Overall status
- Terminated
- Start date
- March 28, 2019
- Completion date
- June 27, 2023
- Enrollment
- 12 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.